Elastic N.V. 8-K Summary: Annual Meeting Results
Business Context and Reporting Period
This Form 8-K reports the results of Elastic N.V.'s Annual General Meeting of Shareholders held on September 30, 2025, in Amsterdam, the Netherlands. The filing covers the voting outcomes for ten proposals presented to shareholders as of the record date of September 2, 2025.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting results.
Material Changes and Voting Results
All ten proposals submitted to shareholders were adopted. Key outcomes include:
- Director Appointments: Ashutosh Kulkarni (executive) and Steven Schuurman (non-executive) were appointed for three-year terms. Both received significant "Against" votes (approx. 28% and 35% respectively) but passed as the "Against" votes did not exceed the two-thirds threshold required to block appointment under the Articles of Association.
- Financial Approvals: Shareholders adopted the Dutch statutory annual accounts for Fiscal Year 2025 (ended April 30, 2025) and granted full discharge to both executive and non-executive directors for their performance during that fiscal year.
- Auditor Ratification: PricewaterhouseCoopers Accountants N.V. was appointed as the external auditor for Dutch statutory accounts, and PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for Fiscal Year 2026.
- Capital Actions: The Board was authorized to issue ordinary shares, restrict pre-emptive rights, and repurchase ordinary shares.
- Executive Compensation: The non-binding advisory vote on executive compensation passed, though it received approximately 14% "Against" votes.
Guidance, Outlook, and Risks
The filing text does not contain management commentary on future guidance, outlook, risks, contingencies, or unusual items. The document is limited to the certification of voting results.
Investor Verification Checklist
- Verify the specific reasons for the elevated "Against" votes on the director appointments (Proposals 1) and executive compensation (Proposal 10) by reviewing the 2025 proxy statement.
- Confirm the details of the share repurchase authorization (Proposal 9), including the maximum number of shares and the duration of the authorization, which are not detailed in this 8-K.
- Review the full Dutch statutory annual accounts for Fiscal Year 2025 to understand the financial performance underlying the discharge of directors.
- Monitor future filings for the execution of the share repurchase program and any new share issuances authorized under Proposals 7 and 8.